Cunningham, MJ; Bock, HA; Serrano, IC; Bechand, B; Vidyadhara, DJ; Bonniwell, EM; Lankri, D; Duggan, P; Nazarova, AL; Cao, AB; Calkins, MM; Khirsariya, P; Hwu, C; Katritch, V; Chandra, SS; McCorvy, JD; Sames, D. Pharmacological mechanism of the non-hallucinogenic 5-HT2A agonist Ariadne and analogs ACS Chem. Neurosci., 15 Dec 2022, n/a. 15.3 MB. https://doi.org/10.1021/acschemneuro.2c00597 #4 MS,NMR,other
6-HO-5-MeO-DMT · 6-Hydroxy-5-methoxy-N,N-dimethyltryptamine · 6-Hydroxybufotenin
4-HO-5-MeO-DMT · 4-Hydroxy-5-methoxy-N,N-dimethyltryptamine · 5-Methoxypsilocin
5-MeO-DMT N-oxide · 5-Methoxy-N,N-dimethyltryptamine N-oxide
4-Cyanomethyl-2,5-dimethoxyamphetamine · DOCNM
MEXP · MeOP · Methoxypiperamide
4,7-Dimethoxy-α-methyltryptamine · 4,7-MeO-AMT
β-HO-5-MeO-DMT · β-Hydroxy-5-methoxy-N,N-dimethyltryptamine
5-Methylpsilocin quinone · 5-Me-DMT-4,7-dione · N,N,5-TMT-4,7-dione
5,7-Dimethoxy-N-methyltryptamine · 5,7-MeO-NMT